glp-1 and hypertension The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: A mini-review of the potential mechanisms Frontiers | GLP-1 and Underlying

46 Finally, Klonoff et al, using the Arcadia patient registry, also found no significant increase in NAION risk in patients taking semaglutide

Similarly, GLP-1 RA use was linked to a reduced risk of bullous pemphigoid compared with insulin (HR 0.65, 95% CI 0.430.99), while comparisons with other antidiabetic drugs were not statistically significant ( Figure 3C )

[DOI] [PMC free article] [PubMed] [Google Scholar] 245.Pappas, T

This mushroom's structure, characterized by long, hanging filaments resembling a lion's mane, sets it apart from other species, contributing to its evocative name and reputation

It adds one more nudge in favour of choosing GLP-1RAs over agents like sulfonylureas or insulin (where feasible), especially in a population already at high risk for thromboembolic and cardiometabolic complications

Moreover, in the SPP/PS1 transgenic AD mouse model, therapy with DA5-CH improved the memory function of AD animals and decreased the levels of amyloid senile plaques and phosphorylated tau protein in the hippocampus [57]